经纬股份 reported revenue of ¥0.14B for the period ended 2026-06-30, -37.3% year on year. Net income was ¥-0.02B, a -17.1% net margin on a 15.6% gross margin. The largest revenue line is 电力工程建设 at 42% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.14B | -37.3% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.03B | — |
| Net income | ¥-0.02B | -289.7% |
| Gross margin | 15.6% | Net margin -17.1% |
| Revenue Q/Q | +25.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 电力工程建设 | ¥0.06B | 42.1% |
| 电力咨询设计 | ¥0.04B | 26.6% |
| 电力设备销售 | ¥0.03B | 20.6% |
| 其他主营业务 | ¥0.01B | 7.2% |
| 其他(补充) | ¥0.00B | 3.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.11B | 84.4% |
| R&D | ¥0.01B | 9.8% |
| SG&A | ¥0.04B | 27.8% |
| Tax & other | ¥-0.01B | -3.9% |
| Item | Amount |
|---|---|
| Total assets | ¥1.74B |
| Total liabilities | ¥0.82B |
| Shareholders' equity | ¥0.92B |
| Equity / assets | 52.9% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 506% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
卡莱特 ・ 汇成真空 ・ 昊帆生物 ・ 仁信新材 ・ 宏景科技 ・ 溯联股份 ・ 星源卓镁 ・ 英特科技 ・ 华人健康 ・ 安培龙 ・ 协昌科技 ・ 阿莱德
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies